Mitochondrial membrane permeabilization in cell death

G Kroemer, L Galluzzi, C Brenner - Physiological reviews, 2007 - journals.physiology.org
Irrespective of the morphological features of end-stage cell death (that may be apoptotic,
necrotic, autophagic, or mitotic), mitochondrial membrane permeabilization (MMP) is …

Rodent models of hepatic ischemia–reperfusion injury: time and percentage-related pathophysiological mechanisms

T Karatzas, AA Neri, ME Baibaki, IA Dontas - Journal of Surgical Research, 2014 - Elsevier
Ischemia and reperfusion (IR) injury remains one of the major problems in liver surgery and
transplantation, which determines the viability of the hepatic tissue after resection and of the …

Trimetazidine revisited: a comprehensive review of the pharmacological effects and analytical techniques for the determination of trimetazidine

A Onay‐Besikci, SA Özkan - Cardiovascular therapeutics, 2008 - Wiley Online Library
Trimetazidine (TMZ) is an effective and well‐tolerated antianginal drug that possesses
protective properties against ischemia‐induced heart injury. Growing interest in metabolic …

[HTML][HTML] Systematic review of randomized controlled trials of pharmacological interventions to reduce ischaemia-reperfusion injury in elective liver resection with …

M Abu-Amara, K Gurusamy, S Hori, G Glantzounis… - HPB, 2010 - Elsevier
Background Vascular occlusion during liver resection results in ischaemia-reperfusion (IR)
injury, which can lead to liver dysfunction. We performed a systematic review and meta …

Neuroprotective Effects of Trimetazidine against Cisplatin‐Induced Peripheral Neuropathy: Involvement of AMPK‐Mediated PI3K/mTOR, Nrf2, and NF‐κB Signaling …

MA Elbaset, SM Afifi, T Esatbeyoglu… - Oxidative Medicine …, 2024 - Wiley Online Library
Cisplatin‐induced peripheral neuropathy (CIPN) is a common and debilitating side effect of
cisplatin chemotherapy used in cancer treatment. This study explored the neuroprotective …

The anti-anginal drug trimetazidine reduces neutrophil-mediated cardiac reperfusion injury

I Tritto, P Wang, P Kuppusamy, R Giraldez… - Journal of …, 2005 - journals.lww.com
Trimetazidine has no hemodynamic/antithrombotic actions. Hence, its anti-ischemic
properties have been mostly attributed to its metabolic effects. However, this issue is not …

Blocking the path to death: anti-apoptotic molecules in ischemia/reperfusion injury of the liver

P Georgiev, F Dahm, R Graf… - Current Pharmaceutical …, 2006 - ingentaconnect.com
This review highlights recent advances in our understanding of intracellular mechanisms
underlying programmed cell death in hepatic ischemia/reperfusion injury. A range of …

Targeting angiogenic and proliferative mediators by montelukast & trimetazidine Ameliorates thioacetamide-induced liver fibrosis in rats

RS Abdelrahman, AA Elnfarawy, AE Nashy… - Toxicology and Applied …, 2025 - Elsevier
Liver fibrosis is a significant health complication with the potential to result in serious
mortality and morbidity. However, there is no standard treatment due to its complex …

New insights on pharmacological and therapeutic potentials of trimetazidine beyond anti-anginal drug: A comprehensive review

D Singh, J Oladimeji-Salami, AJ Akindele - European Journal of …, 2024 - Elsevier
Trimetazidine (TMZ) is a beneficial and well-tolerable anti-anginal drug which has protective
action towards ischemia and reperfusion injury. TMZ performs its anti-ischemic effect by …

Trimetazidine for stable angina pectoris

HR Cross - Expert Opinion on Pharmacotherapy, 2001 - Taylor & Francis
Stable angina pectoris, a symptom of coronary heart disease (CHD), manifests as stress-
induced ischaemic episodes resulting in severe chest pain. Therapeutic aims are to improve …